Cell Well Exim Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 17-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.45 Cr
as on 17-12-2024
- Revenue -5.96%
(FY 2022)
- Profit -6.58%
(FY 2022)
- Ebitda -1.98%
(FY 2022)
- Net Worth -109.06%
(FY 2022)
- Total Assets 0.78%
(FY 2022)
About Cell Well Exim
The Corporate was formerly known as Cell Well Research Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹23.45 Cr.
Renudevi Hisaria and Gautam Agarwal serve as directors at the Company.
- CIN/LLPIN
U46699MH2012PTC231465
- Company No.
231465
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cell Well Exim?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Renudevi Hisaria  | Director | 21-Feb-2018 | Current |
| Gautam Agarwal | Director | 08-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Cell Well Exim.
Cell Well Exim Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.96% decrease. The company also saw a slight decrease in profitability, with a 6.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 109.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cell Well Exim?
In 2021, Cell Well Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tarang Agrro Industries Private LimitedActive 10 years 11 monthsRenudevi Hisaria and Gautam Agarwal are mutual person
- Oss Software Solutions Labs Private LimitedActive 16 years 6 months
Renudevi Hisaria is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 28 Mar 2024 | ₹9.95 Cr | Open |
Indian Bank Creation Date: 28 Mar 2024 | ₹13.50 Cr | Open |
How Many Employees Work at Cell Well Exim?
Unlock and access historical data on people associated with Cell Well Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cell Well Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cell Well Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
